These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29066092)

  • 1. Longitudinal monitoring of liver stiffness by acoustic radiation force impulse imaging in patients with chronic hepatitis B receiving entecavir.
    Wu SD; Ding H; Liu LL; Zhuang Y; Liu Y; Cheng LS; Wang SQ; Tseng YJ; Wang JY; Jiang W
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):227-236. PubMed ID: 29066092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
    Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
    Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Chon YE; Park JY; Myoung SM; Jung KS; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH
    Am J Gastroenterol; 2017 Jun; 112(6):882-891. PubMed ID: 28374814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
    Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Liver Int; 2014 Sep; 34(8):1216-23. PubMed ID: 24267737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
    Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study.
    Dong XQ; Wu Z; Li J; Wang GQ; Zhao H;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):755-763. PubMed ID: 30290019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy.
    Su TH; Liao CH; Liu CH; Huang KW; Tseng TC; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
    Radiology; 2018 Jul; 288(1):293-299. PubMed ID: 29584594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study concerning the value of acoustic radiation force impulse elastography (ARFI) in comparison with transient elastography (TE) for the assessment of liver fibrosis in patients with chronic hepatitis B and C.
    Sporea I; Sirli R; Bota S; Popescu A; Sendroiu M; Jurchis A
    Ultrasound Med Biol; 2012 Aug; 38(8):1310-6. PubMed ID: 22698510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological response.
    Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
    Liver Int; 2018 Jan; 38(1):59-67. PubMed ID: 28557143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.
    Zhang D; Chen M; Wang R; Liu Y; Zhang D; Liu L; Zhou G
    Ultrasound Med Biol; 2015 Jan; 41(1):7-14. PubMed ID: 25308941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
    Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
    World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir.
    Kong Y; Sun Y; Zhou J; Wu X; Chen Y; Piao H; Lu L; Ding H; Nan Y; Jiang W; Xu Y; Xie W; Li H; Feng B; Shi G; Chen G; Li H; Zheng H; Cheng J; Wang T; Liu H; Lv F; Shao C; Mao Y; Sun J; Chen T; Han T; Han Y; Wang L; Ou X; Zhang H; Jia J; You H
    J Viral Hepat; 2019 May; 26(5):576-585. PubMed ID: 30624000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
    Liang X; Xie Q; Tan D; Ning Q; Niu J; Bai X; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Chen Y; Fan R; Sun J; Jia J; Hou J
    J Viral Hepat; 2018 Mar; 25(3):296-305. PubMed ID: 29080299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B.
    Lim SG; Cho SW; Lee YC; Jeon SJ; Lee MH; Cho YJ; Kim SS; Kim YB; Seok JY; Cheong JY; Kim JH
    Hepatogastroenterology; 2011; 58(106):539-45. PubMed ID: 21661428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness and performance of acoustic radiation force impulse in patients with chronic hepatitis B.
    Ozturker C; Karagoz E; Sivrioglu AK; Kara K
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):663-668. PubMed ID: 28151749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort.
    Alem SA; Said M; Anwar I; Abdellatif Z; Elbaz T; Eletreby R; AbouElKhair M; El-Serafy M; Mogawer S; El-Amir M; El-Shazly M; Hosny A; Yosry A
    J Med Virol; 2018 Sep; 90(9):1508-1515. PubMed ID: 29718546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
    Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
    Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    Kim BS; Seo YS; Kim YS; Lee CH; Lee HA; Um SH; Yoo JJ; Kim SG; Suh SJ; Jung YK; Ahn SH; Han KH; Yim HJ; Kim SU;
    J Gastroenterol Hepatol; 2018 Feb; 33(2):503-510. PubMed ID: 28666070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of FibroScan, APRI, and FIB-4 in chronic hepatitis B patients with significant liver histological changes receiving 3-year entecavir therapy.
    Li Q; Chen L; Zhou Y
    Clin Exp Med; 2018 May; 18(2):273-282. PubMed ID: 29350286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.